Glyburide is also known as glibenclamide is a drug belong to sulfonyl urea category and is used to treat type 2 diabetes mellitus. Glyburide helps in lowering blood glucose level by stimulating pancreas to produce more insulin. Glyburide is suggested to take together with exercise and diet and is given by oral route. Common side effects of glyburide are, heartburn, nausea, angioedema etc.
MARKET DYNAMICS
The key market drivers for Glyburide Market are, rising prevalence of type 2 diabetes mellitus across the globe, growing geriatric and obese population, increasing prevalence of genetic disorders. Additionally, high R&D investments by drug companies to develop more effective therapies for management of diabetes is expected to drive market growth during forecast period. Moreover, presence of fixed dose combinations, combination drugs with glyburide is also expected to boost market growth during forecast period. Whereas, some of the side effects associated with drug is expected to hinder market during forecast period.
MARKET SCOPE
The "Glyburide Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Glyburide market with detailed market segmentation by therapeutic effect and application. The Glyburide Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Glyburide Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Glyburide Market is segmented on the basis of therapeutic effect and application. On the basis of therapeutic effect the market is segmented as, diabetes mellitus type 2, blood sugar, others. And on the basis of application the market is segmented as, pediatric patients, geriatric patients.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Glyburide Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Glyburide Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Glyburide Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Glyburide Market in these regions.
MARKET PLAYERS
The report covers key developments in the Glyburide Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Glyburide Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Glyburide market in the global market. Below mentioned is the list of few companies engaged in the Glyburide Market.
The report also includes the profiles of key players in Glyburide Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Pfizer
- Sandoz
- Novartis
- Bristol Myers Squibb
- Sigma-Aldrich
- Hikma Pharmaceuticals
- Amneal Pharmaceuticals
- Sanofi
- Cadila Pharmaceuticals
- Apotex Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.